Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
CNTB
CNTB News & Events
-
Add to Watchlist
Trade CNTB Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
CNTB News
Connect Biopharma Initiates Phase 2 Trial for Rademikibart in Asthma and COPD
Apr 24 2026
NASDAQ.COM
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
Connect Biopharma Reports Positive Clinical Data and Funding
Mar 30 2026
NASDAQ.COM
Connect Biopharma Reports Positive Phase 1 Results for Rademikibart
Mar 30 2026
NASDAQ.COM
Rademikibart Phase 3 Trial Shows Promising Efficacy and Safety Results
Mar 30 2026
Newsfilter
Connect Biopharma Secures $20.2 Million in Private Placement
Mar 30 2026
Newsfilter
CONNECT BIOPHARMA HOLDINGS LTD - RADEMIKIBART SHOWS GOOD TOLERABILITY AND SAFETY SIMILAR TO PLACEBO
Mar 30 2026
moomoo
CONNECT BIOPHARMA HOLDINGS LTD - RADEMIKIBART SHOWS QUICK AND LONG-LASTING EFFECTIVENESS IN PHASE 3 STUDY FOR ATOPIC DERMATITIS OVER 52 WEEKS
Mar 30 2026
moomoo
Show More News
CNTB Events
05/15 08:40
Connect Biopharma Files to Sell 6.13M Ordinary Shares
Connect Biopharma files to sell 6.13M ordinary shares for holders
Show More Events
CNTB Monitor News
No data
CNTB Earnings Analysis
No Data
People Also Watch
